Search - tctmd.com

Displaying 141 - 160 of 437

Sort: Relevancy | Date

News Daily News

Mejores Resultados con SLF de Nueva Generación en EAC Compleja Abonan el Terreno para Comparativas CABG

Todd Neale

March 15, 2016

News Daily News

Better Results With Newer Generation DES in Complex CAD Pave the Way for CABG Comparisons

Todd Neale

March 15, 2016

News Industry News

STENTYS: Results of Self-Apposing Sirolimus-Eluting Stent Trial Published in EuroIntervention

February 28, 2016

News Industry News

Micell Technologies Highlights Data From Published Propensity Analysis of MiStent SES® and Market Standard Xience V® Coronary Stent

February 24, 2016

News Industry News

REVA Achieves Target Patient Enrollment in FANTOM II Trial

February 23, 2016

News Daily News

SORT OUT IV at 5 Years: Better Long-term Safety Confirmed for Second Generation Stents

L.A. McKeown

February 16, 2016

News Daily News

SORT OUT IV al cabo de 5 Años: Se Confirma una Mejor Seguridad a Largo Plazo para los Stents de 2ª Generación

L.A. McKeown

February 16, 2016

News Daily News

5 年时 SORT OUT IV：已证实第二代支架的长期安全性更佳

L.A. McKeown

February 16, 2016

News Industry News

Svelte Medical Systems Announces European Launch of SLENDER IDS™

January 18, 2016

News Industry News

Micell Technologies Announces Completion of Enrollment in MiStent Randomized Trial Against Xience

December 08, 2015

News Daily News

La Complejidad de la ECA No Influye en la Dominación de los SLF Nuevos vs. Viejos

Todd Neale

November 16, 2015

News Daily News

CAD Complexity Does Not Affect Dominance of Newer vs Older DES

Todd Neale

November 16, 2015

News Conference News TCT 2015

Nordic-Baltic Bifurcation III: Kissing Balloon Dilatation Does Not Reduce MACE at 5 Years

October 16, 2015

News Industry News

Study From China Examines Clinical Outcomes Of Two Drug-Eluting Stents With Bioresorbable Polymers Employing Different Elution And Absorption Rates

October 14, 2015

News Industry News

Randomized Trial Of Diabetic Patients In India Finds Paclitaxel-Eluting Stents Failed To Meet Non-Inferiority Compared To Everolimus-Eluting Stents

October 14, 2015

News Conference News TCT 2015

PANDA III: BuMA SES Noninferior to Excel SES for TLF at 1 Year

October 14, 2015

News Conference News TCT 2015

MASTER: Positive Results Seen for Bioresorbable-Polymer DES in STEMI

October 14, 2015

News Conference News TCT 2015

CENTURY II: Bioresorbable-Polymer DES Safe, Effective at 2 Years

October 13, 2015

News Industry News

STENTYS Sirolimus-Eluting Stent Confirms Best-in-Class Performance at 3 Years(1)

October 12, 2015

News Conference News TCT 2015

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

October 12, 2015

Advertisement

Mejores Resultados con SLF de Nueva Generación en EAC Compleja Abonan el Terreno para Comparativas CABG

Better Results With Newer Generation DES in Complex CAD Pave the Way for CABG Comparisons

STENTYS: Results of Self-Apposing Sirolimus-Eluting Stent Trial Published in EuroIntervention

Micell Technologies Highlights Data From Published Propensity Analysis of MiStent SES® and Market Standard Xience V® Coronary Stent

REVA Achieves Target Patient Enrollment in FANTOM II Trial

SORT OUT IV at 5 Years: Better Long-term Safety Confirmed for Second Generation Stents

SORT OUT IV al cabo de 5 Años: Se Confirma una Mejor Seguridad a Largo Plazo para los Stents de 2ª Generación

5 年时 SORT OUT IV：已证实第二代支架的长期安全性更佳

Svelte Medical Systems Announces European Launch of SLENDER IDS™

Micell Technologies Announces Completion of Enrollment in MiStent Randomized Trial Against Xience

La Complejidad de la ECA No Influye en la Dominación de los SLF Nuevos vs. Viejos

CAD Complexity Does Not Affect Dominance of Newer vs Older DES

Nordic-Baltic Bifurcation III: Kissing Balloon Dilatation Does Not Reduce MACE at 5 Years

Study From China Examines Clinical Outcomes Of Two Drug-Eluting Stents With Bioresorbable Polymers Employing Different Elution And Absorption Rates

Randomized Trial Of Diabetic Patients In India Finds Paclitaxel-Eluting Stents Failed To Meet Non-Inferiority Compared To Everolimus-Eluting Stents

PANDA III: BuMA SES Noninferior to Excel SES for TLF at 1 Year

MASTER: Positive Results Seen for Bioresorbable-Polymer DES in STEMI

CENTURY II: Bioresorbable-Polymer DES Safe, Effective at 2 Years

STENTYS Sirolimus-Eluting Stent Confirms Best-in-Class Performance at 3 Years(1)

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content